Cover Image

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data

Risperidone is approved to treat schizophrenia in adolescents and autistic disorder and bipolar mania in children and adolescents. It is also used off-label in younger children for various psychiatric disorders. Several population pharmacokinetic models of risperidone and 9-OH-risperidone have been...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eleni Karatza (Author), Samit Ganguly (Author), Chi D. Hornik (Author), William J. Muller (Author), Amira Al-Uzri (Author), Laura James (Author), Stephen J. Balevic (Author), Daniel Gonzalez (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of Transient Hypoxia versus Prolonged Hypoxia on Satellite Cell Proliferation and Differentiation In Vivo
by: Sukanta Jash, et al.
Published: (2015)

Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations
by: Jacqueline G. Gerhart, et al.
Published: (2022)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
by: Fang Chen, et al.
Published: (2020)

Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
by: Jaydeep Sinha, et al.
Published: (2022)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
by: Paula Soria-Chacartegui, et al.
Published: (2021)

Formulation development and pharmacokinetic studies of long acting in situ depot injection of risperidone
by: Vineet Dubey, et al.
Published: (2022)

Risperidone for Aggressive Behavior in ADHD
by: J Gordon Millichap
Published: (2007)

Risperidone-induced hyperpigmentation
by: Pooja Bains, et al.
Published: (2019)

Risperidone Induced Eruptions
by: Bhatia M . S
Published: (2002)

Risperidone-induced angioedema
by: Caitlin Burton, PharmD, BCPP, et al.
Published: (2024)

Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate
by: Walaa Y. B. Mahdy, et al.
Published: (2023)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
by: Walling DP, et al.
Published: (2021)

Dystonia with MPH/Risperidone Combined Therapy for ADHD
by: J. Gordon Millichap, et al.
Published: (2016)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
by: Walling DP, et al.
Published: (2022)

Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone
by: Yong-Bok Lee
Published: (2016)

Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism
by: Sireen Abdul Rahim Shilbayeh, et al.
Published: (2024)

Nrf2 Activation With CDDO-Methyl Promotes Beneficial and Deleterious Clinical Effects in Transgenic Mice With Sickle Cell Anemia
by: Chibueze A. Ihunnah, et al.
Published: (2022)

Flash Chromatography Application for Risperidone Purification
by: G. S. Trush, et al.
Published: (2015)

Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human
by: David Bibi, et al.
Published: (2024)

Caudal-Rostral Progression of Alpha Motoneuron Degeneration in the SOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis
by: Alastair J. Kirby, et al.
Published: (2022)

EPIDEMIOLOGY OPPORTUNISTIC MYCOSES
by: V. V. Shkarin, et al.
Published: (2017)

Sarcoidosis following sputum positive pulmonary tuberculosis: A rare entity
by: Satyaki Ganguly, et al.
Published: (2012)

Opportunistic infections in pediatrics: when to suspect and how to approach
by: Maria Isabel de Moraes-Pinto, et al.
Published: (2020)

Opportunistic infections in pediatrics: when to suspect and how to approach
by: Maria Isabel de Moraes-Pinto, et al.
Published: (2020)

Opportunistic Screening for Exposure to Bullying in the Pediatric Emergency Department
by: Marlene Seltzer MD, et al.
Published: (2017)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
by: Seyedeh Nesa Rezaeian Shiadeh, et al.
Published: (2023)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
by: Simeon Rüdesheim, et al.
Published: (2022)

Risperidone as a treatment for childhood habitual behavior
by: Victoria Omranifard, et al.
Published: (2013)

Disseminated opportunistic infections masquerading as central nervous system malignancies
by: Ossama Tawfik, et al.
Published: (2022)

Onychomycosis due to opportunistic molds
by: Erick Obed Martínez-Herrera, et al.
Published: (2015)

Conference on Retroviruses and Opportunistic Infections
by: Editorial Office
Published: (2007)

Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population
by: Patricia D. Maglalang, et al.
Published: (2024)

External evaluation of published population pharmacokinetic models of posaconazole
by: Shuqi Huang, et al.
Published: (2022)

Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia
by: Lin Chih-Hsun, et al.
Published: (2012)

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor
by: Samit R. Joshi, et al.
Published: (2020)

Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study
by: Kazeem A. Oshikoya, et al.
Published: (2019)

Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
by: Zhu Young, et al.
Published: (2007)

Data-Based and Opportunistic Integral Concurrent Learning for Adaptive Trajectory Tracking During Switched FES-Induced Biceps Curls
by: Brendon C. Allen, et al.
Published: (2022)

In vivo bone response and interfacial properties of titanium-alloy implant with different designs in rabbit model with time
by: Abhijit Chakraborty, et al.
Published: (2011)

Assessment of exocrine pancreatic function in children and adolescents with direct and indirect testing
by: Puanani Hopson, et al.
Published: (2022)